Alder Biopharmaceuticals Inc. Secures $11,100,000 Series A Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c341ecdc-1098-42f6-8008-633e7b7ed0d1&Preview=1
Date
8/15/2005
Company Name
Alder Biopharmaceuticals Inc.
Mailing Address
11804 North Creek Parkway South Bothell, WA 98011
Company Description
Alder Biopharmaceuticals uniquely identifies, develops, and manufactures novel antibody therapeutics to alleviate human suffering in the autoimmune and inflammatory disease areas. Alder’s management team combines decades of industry experience with a proven track record for identifying and developing novel antibody therapeutics.
Website
http://www.alderbio.com
Transaction Type
Venture Equity
Transaction Amount
$11,100,000
Transaction Round
Series A
Proceeds Purposes
This funding will allow us to develop our lead antibody therapeutic, broaden our product pipeline, and build on our proprietary antibody discovery and manufacturing technologies.
M&A Terms
Venture Investor
Sevin Rosen Funds
Venture Investor
Ventures West
Venture Investor
WRF Capital